Menu Search
Equities

Slottsviken Fastighetsaktiebolag (publ)

  • Add to watchlist
  • Add to portfolio
  • Add an alert
SLOTT B:AKT

Slottsviken Fastighetsaktiebolag (publ)

Actions
  • Price (SEK)30.40
  • Today's Change-2.00 / -6.17%
  • Shares traded759.00
  • 1 Year change-14.61%
  • Beta0.2710
Data delayed at least 15 minutes, as of Feb 17 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Slottsviken Fastighetsaktiebolag (publ), formerly Conpharm AB (publ), is a Sweden-based company involved in real estate sector. The Company owns and manages residential, office and commercial properties in peri-urban locations. Slottsviken Fastighetsaktiebolag (publ) is a real estate company that acquires, manages and develops attractive properties in urban areas with a focus on the Gothenburg region. Its property portfolio includes residential properties; and commercial premises for production, shop/trade, restaurants, industry, workshops, logistics, and offices. The company also invests in securities; and owns and manages intellectual property rights relating to Reumacon and Wartec life science activities.

  • Revenue in SEK (TTM)12.95m
  • Net income in SEK2.29m
  • Incorporated1983
  • Employees1.00
  • Location
    Slottsviken Fastighetsaktiebolag (publ)Kyrkogatan 24GOETEBORG 411 15SwedenSWE
  • Phone+46 18194950
  • Fax+46 854085655
  • Websitehttps://www.slottsviken.se/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		SLOTT B:AKT since
announced		Transaction
value
Savenas 170:18, GothenburgAnnounced04 Jul 202504 Jul 2025Announced-24.75%--
Data delayed at least 15 minutes, as of Feb 17 2026.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.